Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2025-01-01T08:30:08.307Z Has data issue: false hasContentIssue false
  • English
  • Français

COVID-19 Vaccine Acceptance is associated with Vaccine Hesitancy, Perceived Risk and Previous Vaccination Experiences

Published online by Cambridge University Press:  23 December 2021

İlknur Dolu Open the ORCID record for İlknur Dolu [Opens in a new window] ,
Zeynep Turhan  and
Hacer Yalnız Dilcen
İlknur Dolu*
Affiliation:
Department of Nursing, Faculty of Health Science, Bartın University, Bartın, Turkey
Zeynep Turhan
Affiliation:
Department of Social Work, Faculty of Health Science, Bartın University, Bartın, Turkey
Hacer Yalnız Dilcen
Affiliation:
Department of Midwifery, Faculty of Health Science, Bartın University, Bartın, Turkey
*
Corresponding author: İlknur Dolu, Emails: idolu@bartin.edu.tr; ilknurcakirdolu@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

This study examines the factors associated with the willingness to get the coronavirus vaccine among individuals aged 18 and above.

Methods:

This cross-sectional study was conducted in Turkey. The participants aged 18 and older were recruited between December, 2020 and January, 2021 through conventional social media sites. Snowball sampling was used. An anonymous questionnaire consisted of demographics, vaccination experiences, and perceived risk of coronavirus disease.

Results:

1202 women and 651 men were included in the data analysis. Findings showed that demographics, vaccination experience, and perceived risk of getting COVID-19 were explained. 37% of the variance in people’s willingness to get the COVID-19 vaccination was according to hierarchical logistic regression. Furthermore, increasing age, being male, acquiring positive information about COVID-19 vaccines, having a lower level of vaccine hesitancy, the high level of worry about COVID-19, and low level of perceptions of the possibility of becoming infected by the COVID-19 were the main predictors of COVID-19 vaccine willingness.

Conclusions:

Factors affecting adults’ willingness to be inoculated with COVID-19 vaccines were related to demographics, vaccination experiences, and perceived risk of getting COVID-19. We recommend that public health authorities and practitioners should consider these multiple factors regarding vaccine confidence to achieve herd immunity.

Keywords

COVID-19immunizationriskvaccinesvaccine hesitancy
Type
Original Research
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e97
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

World Health Organization. COVID 19 Public Health Emergency of International Concern (PHEIC). https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum. Accessed January 1, 2021.Google Scholar
World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed January 1, 2021.Google Scholar
Ministry of Health of Turkey. COVID-19 Information Page. https://covid19.saglik.gov.tr/?_Dil=2. Accessed January 1, 2021.Google Scholar
World Health Organization. Cumulative Number of Reported Probable Cases of Severe Acute Respiratory Syndrome (SARS). https://www.who.int/csr/sars/country/en/. Accessed January 1, 2021.Google Scholar
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/emergencies/mers-cov/en/. Accessed January 1, 2021.Google Scholar
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/?gclid=CjwKCAiAnIT9BRAmEiwANaoE1R9E0-vV7Ur7hu7Ta6GMVTqnw9bnyVkwq-lnfXYXwL1LrN6afKiCtBoC86cQAvD_BwE. Accessed January 1, 2021.Google Scholar
Patterson, GE, McIntyre, KM, Clough, HE, Rushton, J. Societal impacts of pandemics: Comparing COVID-19 with history to focus our response. Front Public Health. 2021; 9(630449):1–6.CrossRefGoogle ScholarPubMed
Gökçay, G, Keskindemirci, G. Ist Faculty Med. 2020; 23:1–5.Google Scholar
Dodd, RH, Cvejic, E, Bonner, C, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis. 2021; 21(3): 318–319.CrossRefGoogle ScholarPubMed
World Health Organization. The push for a COVID-19 vaccine. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines. Accessed January 1, 2021.Google Scholar
World Health Organization. WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines in the context of limited supply. https://www.who.int/docs/default-source/immunization/sage/covid/sage-prioritization-roadmap-covid19-vaccines.pdf?Status=Temp&sfvrsn=bf227443_2&ua=1. Accessed January 1, 2021.Google Scholar
Özceylan G, Toprak, D, Esen, ES. Vaccine rejection and hesitation in Turkey. Hum Vaccin Immunother. 2020;16(5):1034–1039.Google Scholar
Smith, TC. Vaccine Rejection and Hesitancy: A Review and call to action. Open Forum Infect Dis. 2017;4(3):ofx146.CrossRefGoogle ScholarPubMed
Bertoncello, C, Ferro, A, Fonzo, M, et al. Socioeconomic Determinants in Vaccine Hesitancy and Vaccine Refusal in Italy. Vaccines (Basel). 2020;8(2):276.CrossRefGoogle ScholarPubMed
Rozbroj, T, Lyons, A, Lucke, J. Vaccine-refusing parents' reflections on the way parenthood changed their attitudes to vaccination. J Community Health. 2020;45(1):63–72.CrossRefGoogle Scholar
Bora Başara, B, Soytutan Çağlar, İ, Aygün, A, Özdemir TA. The Ministry of Health of Turkey health statistics yearbook. 2019:84.Google Scholar
MacDonald, NE, SWGoV, Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4.CrossRefGoogle ScholarPubMed
Pugliese-Garcia, M, Heyerdahl, LW, Mwamba, C, et al. Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka. Zambia Vaccine. 2018;36(37):5617–5624.CrossRefGoogle ScholarPubMed
Baumgaertner, B, Ridenhour, BJ, Justwan, F, Carlisle, JE, Miller, CR. Risk of disease and willingness to vaccinate in the United States: A population-based survey. PLoS Med. 2020;17(10):e1003354.CrossRefGoogle ScholarPubMed
García, LY, Cerda, AA. Acceptance of a COVID-19 vaccine: A multifactorial consideration. Vaccine. 2020;38(48):7587.CrossRefGoogle ScholarPubMed
Neumann-Böhme, S, Varghese, NE, Sabat, I, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–982.CrossRefGoogle ScholarPubMed
COCONEL Group. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. Lancet Infect Dis. 2020;20(7):769–770.CrossRefGoogle Scholar
Furman, FM, Zgliczyński, WS, Jankowski, M, Baran, T, Szumowski, Ł, Pinkas, J. The state of vaccine confidence in Poland: A 2019 nationwide cross-sectional survey. Int J Environ Res Public Health. 2020;17(12):45–65.CrossRefGoogle Scholar
Blasi, F, Aliberti, S, Mantero, M, Centanni, S. Compliance with anti-H1N1 vaccine among healthcare workers and general population. Clin Microbiol Infect. 2012;18 Suppl 5:37–41.CrossRefGoogle ScholarPubMed
Karlsson, LC, Soveri, A, Lewandowsky, S, et al. Fearing the disease or the vaccine: The case of COVID-19. Personality and Individual Differences. 2021;172(110590):1–11.CrossRefGoogle ScholarPubMed
Dryhurst, S, Schneider, CR, Kerr, J, et al. Risk perceptions of COVID-19 around the world. J Risk Research. 2020:1–13.Google Scholar
Larson, HJ, Jarrett, C, Schulz, WS, et al. Measuring vaccine hesitancy: The development of a survey tool. Vaccine. 2015;33(34):4165-75.CrossRefGoogle ScholarPubMed
Shapiro, GK, Tatar, O, Dube, E, et al. The vaccine hesitancy scale: Psychometric properties and validation. Vaccine. 2018;36(5):660–667.CrossRefGoogle ScholarPubMed
Yalnız Dilcen, H, Dolu, I, Turhan, Z. Asi Teredduttu Olcegi Gecerlilik Guvenirlik Calismasi [Validity and Reliability Study of the Vaccine Hesitancy Scale]. Presented at: Uluslararası Anadolu Ebeler Derneği Kongresi; 20-22 November 2020; Online Congress.Google Scholar
Faour-Klingbeil, D, Osaili, TM, Al-Nabulsi, AA, Jemni, M, Todd, DEC. The public perception of food and non-food related risks of infection and trust in the risk communication during COVID-19 crisis: A study on selected countries from the Arab region. Food Control. 2021;121(10761).CrossRefGoogle Scholar
Alsubaie, S, Hani Temsah, M, Al-Eyadhy, AA, et al. Middle East Respiratory Syndrome Coronavirus epidemic impact on healthcare workers' risk perceptions, work and personal lives. J Infect Dev Ctries. 2019;13(10):920–926.CrossRefGoogle Scholar
Bovbjerg, DH, Keefe, FJ, Soo, MS, et al. Persistent breast pain in post-surgery breast cancer survivors and women with no history of breast surgery or cancer: Associations with pain catastrophizing, perceived breast cancer risk, breast cancer worry, and emotional distress. Acta Oncol. 2019;58(5):763–768.CrossRefGoogle ScholarPubMed
Park, D, Lee, HJ, Lee, SH. Generalization of conscious fear is positively correlated with anxiety, but not with depression. Exp Neurobiol. 2018;27(1):34–44.CrossRefGoogle Scholar
Ahorsu, DK, Lin, CY, Imani, V, Saffari, M, Griffiths, MD, Pakpour, AH. The Fear of COVID-19 Scale: Development and initial validation. Int J Ment Health Addict. 2020:1–9.Google ScholarPubMed
Bakioğlu, F, Korkmaz, O, Ercan, H. Fear of COVID-19 and positivity: Mediating role of intolerance of uncertainty, depression, anxiety, and stress. Int J Ment Health Addict. 2020:1–14.Google ScholarPubMed
Salali, GD, Uysal, MS. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol Med. 2020:1–3.Google ScholarPubMed
Feleszko, W, Lewulis, P, Czarnecki, A, Waszkiewicz, P. Flattening the curve of COVID-19 vaccine rejection—a global overview. 2020:1–11.CrossRefGoogle Scholar
Lazarus, JV, Ratzan, SC, Palayew, A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;225-228.Google ScholarPubMed
Wang, J, Jing, R, Lai, X, et al. Acceptance of COVID-19 vaccination during the covid-19 pandemic in China. Vaccines (Basel). 2020;8(3):482.CrossRefGoogle ScholarPubMed
Fisher, KA, Bloomstone, SJ, Walder, J, Crawford, S, Fouayzi, H, Mazor, KM. Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults. Ann Intern Med. 2020;173(12):964–973.CrossRefGoogle Scholar
Harapan, H, Wagner, AL, Yufika, A, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: A cross-sectional study in Indonesia. Front Public Health. 2020;8:381.CrossRefGoogle ScholarPubMed
Fink, G, Orlova-Fink, N, Schindler, T, et al. Inactivated trivalent influenza vaccine is associated with lower mortality among Covid-19 patients in Brazil. 2020:1–29.CrossRefGoogle Scholar
Ward JK, Alleaume C, Peretti-Watel P, Group C. The French public’s attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc Sci Med. 2020;265:113414.CrossRefGoogle Scholar
Smith, N, Graham, T. Mapping the anti-vaccination movement on Facebook. Information, Communication & Society. 2017;22(9):1310–1327.CrossRefGoogle Scholar
Committee on Equitable Allocation of Vaccine for the Novel Coronavirus. Framework for Equitable Allocation of COVID-19 Vaccine. 2020.Google Scholar
Supplementary material: File

Dolu et al. supplementary material

Dolu et al. supplementary material

Download Dolu et al. supplementary material(File)
File 60.1 KB